Insights from Aptos Biosciences CEO on Drug Development and Healthcare Systems at Blum Burton Conference | William Rice, CEO, Aptose Biosciences Inc . 00:10:00

Share On Facebook Share On Twitter

The CEO of a biotech company discusses the progress and potential of their drug development programs for treating acute myeloid leukemia and b-cell malignancies, along with insights on healthcare systems, during an interview at the Blum Burton health care investment conference in Toronto.

Recent Videos